Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Angiolink Corporation logo — Experience precision in arterial closure with advanced vascu...

Angiolink Corporation

Experience precision in arterial closure with advanced vascular stapling solutions.

Founded 1999 Series B Total: $24.20M Biotechnology, Health Care +1

General Information

Company Name Angiolink Corporation
Founded Year 1999
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Angiolink Corporation. To contact Angiolink Corporation, visit angiolink.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Angiolink Corporation

Angiolink Corporation is a biotechnology, health care, and medical devices company founded in 1999. The company's slogan "Experience precision in arterial closure with advanced vascular stapling solutions" epitomizes its focus on providing innovative medical solutions. Angiolink offers the EVS vascular closure system, an arterial stapling device designed for closing holes and punctures in arteries during catheter-based surgical procedures such as angioplasty and angiograms. The latest notable milestone for Angiolink Corporation was a $13.60M Series B investment, which took place on 10th September 2003. This injection of capital was provided by prominent investors including BioVentures Investors, Boston Finance & Equity, JHK Investments, and IDP Industrial Development Partners. This infusion of funds serves as a testament to the confidence that key market players have in Angiolink Corporation and its innovative solutions. With a strong focus on precision and advancement in vascular closure, the company is well-positioned to make a significant impact in the medical devices industry.

Taxonomy: vascular closure, arterial stapling, surgical procedures, catheter-based surgery, angioplasty, angiograms, vascular stapling solutions, advanced medical devices, arterial closure technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $13.60M 4
BioVentures Investors Boston Finance & Equity JHK Investments
BioVentures Investors, Boston Finance & Equity +2
10 Sep 2003
Series A $10.60M 2
BioVentures Investors Boston Finance & Equity
BioVentures Investors, Boston Finance & Equity
17 Sep 2002

Angiolink Corporation Alternatives & Competitors

View All Alternatives
Angiolink Corporation vs
Covellus
Covellus United States

The industry’s first modular catheter system.

Non Equity Assistance
1 employees
Health Care, Medical Devices
Angiolink Corporation vs
Lexington Medical, Inc
Lexington Medical, Inc United States

The stapler of choice for surgeons who prioritize precision. Smart stapling. Simply superior.

Series B
125 employees
Health Care, Manufacturing
Angiolink Corporation vs
Zippline Inc
Zippline Inc

Innovative tissue repair devices bringing rapid, non-invasive, and seamless skin closure for superio...

Series F
3 employees
Health Care, Medical Devices
View all alternatives

FAQ About Angiolink Corporation

Experience precision in arterial closure with advanced vascular stapling solutions.
Angiolink Corporation was founded in 1999.
Angiolink Corporation operates in Biotechnology, Health Care and Medical Devices. Its work centres on vascular closure, arterial stapling, surgical procedures and catheter-based surgery.
Angiolink Corporation has completed 2 funding rounds, raising a total of $24.20M. The latest funding stage is Series B.
Top alternatives and competitors to Angiolink Corporation include Covellus, Lexington Medical, Inc, Zippline Inc, Vivasure Medical Ltd., BMEYE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Angiolink Corporation and Covellus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Angiolink Corporation, https://bouncewatch.com/company/angiolink-corporation, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes